Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia · Delayed Price · Currency is AUD 3.890
+0.410 (11.78%)
Jul 18, 2025, 4:21 PM AEST
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 1.13 billion as of July 17, 2025. Its market cap has decreased by -27.48% in one year.
Market Cap
1.13B
Enterprise Value
1.01B
Revenue
10.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.89
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 1.13B, an increase of 192.94%. That is a compound annual growth rate of 31.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 1.13B | -15.87% |
| Dec 31, 2024 | 1.34B | 168.49% |
| Dec 29, 2023 | 498.26M | 93.82% |
| Dec 30, 2022 | 257.07M | 35.63% |
| Dec 31, 2021 | 189.54M | -50.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 116.99B |
| Pro Medicus | 33.11B |
| Cochlear | 19.70B |
| Sonic Healthcare | 13.47B |
| Ramsay Health Care | 8.77B |
| Telix Pharmaceuticals | 7.94B |
| Ansell | 4.35B |
| Regis Healthcare | 2.20B |